Plains GP Holdings, L.P. (NYSE:PAGP – Get Free Report) was the target of some unusual options trading activity on Thursday. Stock investors bought 10,187 call options on the company. This is an increase of approximately 685% compared to the average volume of 1,297 call options.
Plains GP Stock Performance
NYSE PAGP traded up $0.84 during trading hours on Thursday, reaching $21.51. 2,446,835 shares of the company were exchanged, compared to its average volume of 1,976,561. The stock has a market capitalization of $4.25 billion, a P/E ratio of 25.26 and a beta of 1.58. The company has a quick ratio of 0.92, a current ratio of 1.01 and a debt-to-equity ratio of 0.49. Plains GP has a 1 year low of $15.78 and a 1 year high of $21.53. The business’s 50 day simple moving average is $18.92 and its 200-day simple moving average is $18.84.
Plains GP Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Friday, January 31st will be paid a dividend of $0.38 per share. The ex-dividend date is Friday, January 31st. This represents a $1.52 annualized dividend and a dividend yield of 7.07%. This is a positive change from Plains GP’s previous quarterly dividend of $0.32. Plains GP’s dividend payout ratio (DPR) is presently 149.41%.
Hedge Funds Weigh In On Plains GP
Analysts Set New Price Targets
PAGP has been the subject of a number of recent analyst reports. Wolfe Research upgraded Plains GP from a “peer perform” rating to an “outperform” rating and set a $22.00 price target for the company in a report on Friday, January 10th. StockNews.com raised Plains GP from a “hold” rating to a “buy” rating in a research note on Friday, November 8th. Wells Fargo & Company lowered Plains GP from an “overweight” rating to an “equal weight” rating and dropped their price target for the company from $22.00 to $20.00 in a research note on Wednesday, December 18th. Barclays raised their price objective on shares of Plains GP from $18.00 to $19.00 and gave the stock an “underweight” rating in a research report on Thursday. Finally, Morgan Stanley downgraded shares of Plains GP from an “overweight” rating to an “equal weight” rating and dropped their target price for the company from $22.00 to $19.00 in a research report on Friday, October 25th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, Plains GP presently has an average rating of “Hold” and a consensus target price of $20.22.
Read Our Latest Analysis on Plains GP
About Plains GP
Plains GP Holdings, L.P., through its subsidiary, Plains All American Pipeline, L.P., owns and operates midstream infrastructure systems in the United States and Canada. It operates in two segments, Crude Oil and Natural Gas Liquids (NGLs). The company engages in the gathering and transporting crude oil and NGLs using pipelines, gathering systems, and trucks.
See Also
- Five stocks we like better than Plains GP
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- Short Selling: How to Short a Stock
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- Are Penny Stocks a Good Fit for Your Portfolio?
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Plains GP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plains GP and related companies with MarketBeat.com's FREE daily email newsletter.